LAST PRICE - AT THE CLOSE
CURE is DOWN -14% since the begininning of the year
CURE is UP 9% ABOVE 20 day SMA
CURE is DOWN -2% BELOW 200 day SMA
PROFITABLE: N/A
EPS: N/A
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: N/A
 |
THE STOCK IS 36.1% AWAY FROM ALL-TIME HIGHS OF $149.575 |
 |
CURE IS DOWN -14% SINCE THE BEGINNING OF THE YEAR |
 |
CURE IS UP 33% OVER THE PAST 12 MONTHS |
 |
CURE IS UP 6% OVER THE PAST 1 MONTH |
 |
N/A% OF ALL CURE INVESTORS ARE BETTING AGAINST CURE |
 |
NUM INVESTORS SHORT CURE HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
CURE moved down 0.45 in the previous minute |
 |
CURE is up 0.17 over the last hour |
 |
CURE is up 6.2% over the last 5 days |
 |
CURE is 6.6 above its 8 day SMA |
| $93.91 |   DAY |
$96.47 |
| $88.58 | PREVIOUS DAY |
$92.80 |
| $85.48 | WEEK |
$92.80 |
| $82.41 | MONTH |
$92.80 |
| $66.00 | YEAR |
$123.80 |
CURE is mentioned N/A less than normal on 
CURE is mentioned N/A times in an average day on 
